TrialBlood2011

Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin.

Hugo F Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.